The combined BPC-157 and TB-500 preparation in a metered intranasal bottle — both mechanisms, no reconstitution step.
- Content
- 30mg total in a metered 30ml bottle
- Presentation
- ready-to-use metered intranasal solution; no reconstitution step
- Purity
- ≥99% by HPLC, identity confirmed by mass spectrometry
- Released against
- the Certificate of Analysis for its own batch
About BPC-157 / TB-500 Nasal Spray
This supplies BPC-157 and TB-500 together in solution in a metered 30ml intranasal bottle. The two compounds and the rationale for combining them are the same as for the vial preparation: angiogenic signalling from one, actin-dependent cell migration from the other, with no mechanistic overlap between them.
Because the preparation arrives in solution at a fixed concentration, both the ratio and the concentration are set, which makes it a convenient screening instrument and a poor instrument for anything that needs either varied.
What the research covers
Suited to exploratory work where the question is whether a dual-mechanism intervention shifts an outcome. Not suited to attribution: an effect cannot be assigned to either component from this preparation alone.
For mechanistic work, run BPC-157 and TB-500 as single agents; the comparison page explains why the two are usually studied together. The tissue repair research peptides hub sets out the mechanisms in this group.
Handling BPC-157 / TB-500 Nasal Spray
Supplied as a metered intranasal preparation, so there is no reconstitution step and no opportunity for a reconstitution error — the concentration is fixed at what is supplied, which removes one variable and forecloses another.
Store cold and upright, away from light. Two peptides sharing one aqueous solution means the stability of the preparation is governed by whichever degrades first, so usable life is shorter than either component would have alone in the dry state.
Other formats
The same combination is supplied as a lyophilised BPC-157 / TB-500 blend, and each component is available as a single compound: BPC-157, TB-500 and BPC-157 nasal spray.
Common questions about BPC-157 / TB-500 Nasal Spray
What does this preparation contain?
BPC-157 and TB-500 together in solution. BPC-157 is studied for angiogenic signalling and TB-500 for actin-dependent cell migration, two mechanisms that do not overlap.
Can an effect be attributed to one component?
No. A fixed combination cannot show which component produced an effect or whether components interacted. That requires the single compounds run alongside it.
Can the ratio between components be changed?
No. The ratio is fixed in the vial, so studies where the ratio is the variable of interest need the single compounds.
How long does the spray remain usable?
Two peptides share one solution, so usable life is set by whichever degrades first. Keep it cold, upright and dark.
